Phase 2 Plaque Psoriasis trials recruiting now

All Plaque Psoriasis trials, every phase

Other phases for Plaque Psoriasis

Phase 2 Plaque Psoriasis trials

• A Study to Evaluate the Efficacy and Safety of CS32582 in Participants With Moderate to Severe Plaque Psoriasis
  NCT07129382 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 11 locations
• An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
  NCT07449702 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 32 locations
• Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis
  NCT07474792 · Phase: Phase 2 · Ages: 18 Years to 79 Years · Sex: All (male and female) · 39 locations
• Efficacy and Safety of ICP-332 Versus Placebo in Participants With Moderate to Severe Plaque Psoriasis
  NCT07251998 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque Psoriasis
  NCT06058546 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 12 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.